CD24 and neoplasm: This phenotype was demonstrated in SK-N-AS tumors, whose poor expression of CD24 was previously documented in vitro but yielded a dramatic increase in vivo, suggesting that the upregulation of CD24 offered a selective advantage for tumor growth (36).